SCHEMBL23762272

SCHEMBL23762272

CC(C)(C)OC(=O)N1CCc2ccc(Oc3ccnc4c3c(-c3cc(NC(=O)Oc5ccccc5)no3)cn4COCCS(C)(C)C)cc2C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ PTK2 Q05397 1/20 0.33
▸ NR1H2 P55055 1/20 0.33
▸ GCK P35557 4/20 0.33
▸ BTK Q06187 1/20 0.33
▸ MAPT P10636 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ ESR2 Q92731 1/20 0.30
▸ PORCN Q9H237 1/20 0.30
▸ MAP3K5 Q99683 1/20 0.30
▸ ABCB1 P08183 1/20 0.30
▸ LIPE Q05469 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29836482 0.93 NR1H2 (0.34) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762270 0.93 NR1H2 (0.34) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762264 0.89 NR1H2 (0.36) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762209 0.88 NR1H2 (0.40) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23751229 0.86 MAPT (0.34) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL23762181 0.85 NR1H2 (0.35) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762097 0.84 ACHE (0.39) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762200 0.82 NR1H2 (0.39) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL23762190 0.82 NR1H2 (0.40) ACACBJAK2JAK3PTK2NR1H2
SCHEMBL22802663 0.82 NR1H2 (0.41) ACACBJAK2JAK3PTK2NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS ROCK1, ROCK2, RHOA ACACB 2494/4885JAK2 946/4885JAK3 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback